The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery.
Weigelt
Johan
J
Structural Genomics Consortium, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. johan.weigelt@ki.se
D022126:Access to Information; D002626:Chemistry, Pharmaceutical / Q000191:economics; D055808:Drug Discovery / Q000191:economics / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics; D017048:Health Care Costs